|
ZNF326 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63435931455069E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15899956298904E-10 |
| Normal-vs-Stage2 |
5.64640001421424E-09 |
| Normal-vs-Stage3 |
3.63820085169664E-13 |
| Normal-vs-Stage4 |
3.18479687066997E-11 |
| Stage1-vs-Stage2 |
2.635400E-01 |
| Stage1-vs-Stage3 |
1.023560E-02 |
| Stage1-vs-Stage4 |
2.853700E-02 |
| Stage2-vs-Stage3 |
4.394800E-01 |
| Stage2-vs-Stage4 |
3.458000E-01 |
| Stage3-vs-Stage4 |
8.382200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.37965244468342E-13 |
| Normal-vs-AfricanAmerican |
3.81339999999675E-05 |
| Normal-vs-Asian |
1.6176999999562E-06 |
| Caucasian-vs-AfricanAmerican |
8.677800E-01 |
| Caucasian-vs-Asian |
3.451400E-01 |
| AfricanAmerican-vs-Asian |
6.136200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82363021852916E-12 |
| Normal-vs-Female |
1.8508528043526E-12 |
| Male-vs-Female |
6.540800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.62999988243484E-10 |
| Normal-vs-Age(41-60Yrs) |
3.63342689269075E-12 |
| Normal-vs-Age(61-80Yrs) |
1.73527858748912E-12 |
| Normal-vs-Age(81-100Yrs) |
2.435200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.048100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.476100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.748420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.602000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.629200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.097800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.826600E-04 |
| Classical-VS-Follicular |
3.179800E-03 |
| Classical-VS-Other |
7.833800E-01 |
| Classical-VS-Normal |
5.16959808294359E-11 |
| Tall-VS-Follicular |
3.116000E-01 |
| Tall-VS-Other |
3.545200E-01 |
| Tall-VS-Normal |
1.53740353781018E-11 |
| Follicular-VS-Other |
5.189000E-01 |
| Follicular-VS-Normal |
1.8660961664807E-11 |
| Other-VS-Normal |
1.418220E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.11368725142347E-13 |
| Normal-vs-N1 |
7.19039999763638E-08 |
| N0-vs-N1 |
5.420400E-01 |
|
|
